Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
23-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #27203
advertisement
Costa VP
13
Showing records 1 to 13 |
Display all abstracts from
Costa VP
108260
Association of variants in the (rs7137828), (rs2745572) and (rs35934224) genes as risk factors for primary open-angle glaucoma development in a Brazilian cohort
Rodrigues TAR
Ophthalmic Genetics
2023; 44: 246-252
108400
Selective laser trabeculoplasty versus micropulse laser trabeculoplasty for intraocular pressure control in patients with primary open angle glaucoma: a 12-month retrospective comparative study
Pimentel RL
Lasers in Medical Science
2023; 38: 102
108087
The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma
Goulart Nacácio E Silva S
European Journal of Ophthalmology
2023; 0: 11206721231161101
108260
Association of variants in the (rs7137828), (rs2745572) and (rs35934224) genes as risk factors for primary open-angle glaucoma development in a Brazilian cohort
de Souza BB
Ophthalmic Genetics
2023; 44: 246-252
108087
The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma
Occhiutto ML
European Journal of Ophthalmology
2023; 0: 11206721231161101
108400
Selective laser trabeculoplasty versus micropulse laser trabeculoplasty for intraocular pressure control in patients with primary open angle glaucoma: a 12-month retrospective comparative study
Alves Júnior RR
Lasers in Medical Science
2023; 38: 102
108087
The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma
Costa VP
European Journal of Ophthalmology
2023; 0: 11206721231161101
108400
Selective laser trabeculoplasty versus micropulse laser trabeculoplasty for intraocular pressure control in patients with primary open angle glaucoma: a 12-month retrospective comparative study
Lima WMML
Lasers in Medical Science
2023; 38: 102
108260
Association of variants in the (rs7137828), (rs2745572) and (rs35934224) genes as risk factors for primary open-angle glaucoma development in a Brazilian cohort
Bertozzo VHE
Ophthalmic Genetics
2023; 44: 246-252
108400
Selective laser trabeculoplasty versus micropulse laser trabeculoplasty for intraocular pressure control in patients with primary open angle glaucoma: a 12-month retrospective comparative study
Dantas LOR
Lasers in Medical Science
2023; 38: 102
108260
Association of variants in the (rs7137828), (rs2745572) and (rs35934224) genes as risk factors for primary open-angle glaucoma development in a Brazilian cohort
de Castro JNP
Ophthalmic Genetics
2023; 44: 246-252
108400
Selective laser trabeculoplasty versus micropulse laser trabeculoplasty for intraocular pressure control in patients with primary open angle glaucoma: a 12-month retrospective comparative study
Costa VP
Lasers in Medical Science
2023; 38: 102
108260
Association of variants in the (rs7137828), (rs2745572) and (rs35934224) genes as risk factors for primary open-angle glaucoma development in a Brazilian cohort
Camargo ACL; Costa FF; Schimiti RB; Costa VP; De Vasconcellos JPC; de Melo MB
Ophthalmic Genetics
2023; 44: 246-252
Issue
23-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept